A Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of Two Different Doses of a Topical Minocycline Foam Compared to Vehicle in the Treatment of Papulopustular Rosacea - Study FX2015-10.

Trial Profile

A Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of Two Different Doses of a Topical Minocycline Foam Compared to Vehicle in the Treatment of Papulopustular Rosacea - Study FX2015-10.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Feb 2018

At a glance

  • Drugs Minocycline (Primary)
  • Indications Rosacea
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms EMIRA
  • Sponsors Foamix
  • Most Recent Events

    • 02 Feb 2018 Results (n=232) assessing the efficacy and safety of two doses of topical minocycline foam with that of vehicle foam for the treatment of papulopustular rosacea, were published in the American Journal of Clinical Dermatology.
    • 12 Jun 2017 Results published in a Foamix media release.
    • 15 Nov 2016 According to a Foamix Pharmaceuticals media release, status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top